Human_JJ
herpesvirus_NN
6_CD
variant_JJ
A_NN
,_,
but_CC
not_RB
variant_JJ
B_NN
,_,
infects_VBZ
EBV-positive_JJ
B_NN
lymphoid_JJ
cells_NNS
,_,
activating_VBG
the_DT
latent_JJ
EBV_NN
genome_NN
through_IN
a_DT
BZLF-1-dependent_JJ
mechanism_NN
._.

Human_JJ
herpesvirus_NN
6_CD
,_,
a_DT
predominantly_RB
T_NN
lymphotropic_JJ
virus_NN
,_,
has_VBZ
been_VBN
recently_RB
shown_VBN
to_TO
infect_VB
some_DT
EBV_NN
-_:
positive_JJ
B_NN
cell_NN
lines_NNS
,_,
and_CC
to_TO
induce_VB
in_IN
them_PRP
the_DT
activation_NN
of_IN
the_DT
EBV_NN
lytic_JJ
cycle_NN
._.

Here_RB
we_PRP
have_VBP
confirmed_VBN
and_CC
extended_VBD
such_JJ
observations_NNS
,_,
showing_VBG
that_IN
-LRB-_-LRB-
1_LS
-RRB-_-RRB-
this_DT
phenomenon_NN
is_VBZ
restricted_JJ
to_TO
the_DT
variant_JJ
A_NN
of_IN
HHV-6_NN
:_:
in_IN
fact_NN
two_CD
isolates_NNS
belonging_VBG
to_TO
the_DT
HHV-6_NN
variant_NN
B_NN
-LRB-_-LRB-
BA92_NN
and_CC
Z29_NN
-RRB-_-RRB-
were_VBD
neither_CC
able_JJ
to_TO
infect_VB
any_DT
B_NN
cell_NN
line_NN
,_,
independently_RB
of_IN
the_DT
EBV_NN
status_NN
,_,
nor_CC
to_TO
induce_VB
the_DT
EBV_NN
genome_NN
expression_NN
._.

The_DT
only_RB
exception_NN
is_VBZ
represented_VBN
by_IN
the_DT
P3HR1_NN
cells_NNS
,_,
in_IN
which_WDT
,_,
however_RB
,_,
the_DT
infection_NN
by_IN
the_DT
variant_JJ
B_NN
does_VBZ
not_RB
determine_VB
induction_NN
of_IN
EBV_NN
antigens_NNS
;_:
-LRB-_-LRB-
2_LS
-RRB-_-RRB-
the_DT
presence_NN
of_IN
the_DT
EBV_NN
genome_NN
contributes_VBZ
to_TO
the_DT
susceptibility_NN
of_IN
the_DT
B_NN
cell_NN
lines_NNS
to_TO
HHV-6_NN
infection_NN
,_,
increasing_VBG
the_DT
binding_VBG
sites_NNS
and_CC
the_DT
percentage_NN
of_IN
infectable_JJ
cells_NNS
,_,
as_IN
detected_VBN
by_IN
immunoelectron_NN
microscopy_NN
;_:
and_CC
-LRB-_-LRB-
3_LS
-RRB-_-RRB-
HHV-6_NN
infected_JJ
T_NN
cells_NNS
,_,
transfected_VBN
with_IN
plasmids_NNS
bearing_VBG
the_DT
promoter_NN
regions_NNS
of_IN
the_DT
EBV_NN
early_JJ
genes_NNS
BZLF1_NN
and_CC
BMRF1_NN
,_,
show_VBP
a_DT
strong_JJ
transactivation_NN
of_IN
these_DT
promoters_NNS
._.

